Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes
Clinical trial NCT07541456 · COMPLETED
Trial details
- NCT number
- NCT07541456
- Sponsor
- Dr. Zarmina Younes
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2025-11-08
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.